Taxtore (also known by its generic name docetaxel) is a type of chemotherapy drug that has been used to treat breast cancer as well as other types of cancer. The drug is given in an IV form and is a part of the taxanes family.
What is the risk of using it?
Pharmaceutical company Sanofi – Aventis who is the developer of the drug sent out a press release in 2007 highlighting the benefits of Taxotere when used in a clinical study. Sanofi – Aventis did not make known to the FDA, consumers, and health care workers that permanent hair loss was a side effect noted in patients who took the drug. The FDA released a statement in December of 2015 disclosed that they had required Sanofi-Aventis to modify Taxotere’s label to include the risk of permanent hair loss. Even though hair loss during chemotherapy treatment is a common side effect, those patients receiving Taxotere for chemotherapy were not informed that their hair loss could be permanent.
I think I might have a claim? What can I do next?
Permanent hair loss is a very emotional and disabling condition, especially for cases involving patients who are female. Our firm is currently looking into claims for women who have been afflicted with permanent hair loss as a result of using Taxotere for chemotherapy treatment for breast cancer. Contact us at (303) 327-9988 if you or a loved one has experienced permanent hair loss as a result of using Taxotere.